Real-world Assessment of 2879 COVID-19 Patients Treated With Monoclonal Antibody Therapy: A Propensity Score-Matched Cohort Study.

Megan H CooperPaul A ChristensenEric SalazarKatherine K PerezEdward A GravissDuc NguyenJames M MusserHoward J HuangMichael G Liebl

Published in: Open forum infectious diseases (2021)

Treatment with bamlanivimab, bamlanivimab-etesevimab, or casirivimab-imdevimab significantly decreased the number of patients who progressed to severe COVID-19 disease and required hospitalization.

Keyphrases

monoclonal antibody
coronavirus disease
sars cov
early onset